Evidence map›Paper›PMID 29066915›Full record

ArticleOncoTargets and therapy2017

Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population.

N Trachu, E Sirachainan, N Larbcharoensub, W Rattanadech, S Detarkom, N Monnamo, K Kamprerasart, D MunTham, C Sukasem, T Reungwetwattana

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

N TrachuResearch Center, Faculty of Medicine Ramathibodi Hospital.
E SirachainanDivision of Medical Oncology, Department of Medicine.
N LarbcharoensubDivision of Anatomical Pathology, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University.
W RattanadechDivision of Medical Oncology, Department of Medicine.
S DetarkomDivision of Medical Oncology, Department of Medicine.
N MonnamoResearch Center, Faculty of Medicine Ramathibodi Hospital.
K KamprerasartDivision of Anatomical Pathology, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University.
D MunThamSection for Mathematic, Faculty of Science and Technology, Rajamangala University of Technology Suvarnabhumi.
C SukasemDivision of Pharmacogenomics and Personalized Medicine, Department of Pathology.
T ReungwetwattanaDivision of Medical Oncology, Department of Medicine.
Ramathibodi Hospital · THRajamangala University of Technology Isan · THPharmacoGenetics (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores genomic alterations in cholangiocarcinoma (CCC) tissues in Thai patients. We identified and reviewed the records of patients who had been diagnosed with CCC and for whom sufficient tumor samples for DNA and RNA extraction were available in our database. The specimens were explored for

Indexed as

cholangiocarcinomagene alterationstargeted therapy

Identifiers

PMID29066915
PMCPMC5644605
OpenAlexW2762813296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.